1. Home
  2. FF vs NKTX Comparison

FF vs NKTX Comparison

Compare FF & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$4.33

Market Cap

212.3M

Sector

Industrials

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.91

Market Cap

188.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
NKTX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
188.9M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
FF
NKTX
Price
$4.33
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$11.33
AVG Volume (30 Days)
303.8K
640.0K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
11.88
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.63
52 Week High
$5.12
$3.65

Technical Indicators

Market Signals
Indicator
FF
NKTX
Relative Strength Index (RSI) 53.28 48.32
Support Level $3.84 $2.59
Resistance Level $4.45 $3.35
Average True Range (ATR) 0.17 0.21
MACD -0.00 -0.01
Stochastic Oscillator 93.33 42.65

Price Performance

Historical Comparison
FF
NKTX

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: